Rare diseases
Investigational molecules
Locations
Back to Poland12 clinical trials in Plock, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
PolandStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
PolandPolandStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
PolandStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
PolandStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
PolandStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PolandStudy on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma
PolandStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic obstructive pulmonary disease (COPD) treatments, investigating new therapeutic combinations and their effects on respiratory function.
Studies aim to improve quality of life for patients with moderate to severe respiratory conditions.
Groundbreaking trials exploring heart failure prevention and innovative treatments for cardiac conditions, including novel drug combinations.
Research focuses on reducing cardiovascular events and improving patient outcomes.
Clinical investigations evaluating new asthma treatment delivery systems and medications, with particular attention to safety and tolerability.
Studies aim to advance inhaler technology and improve treatment options for asthma patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
